Participants receiving Tezepelumab experienced a significant reduction in nasal polyps, need for surgery and systemic corticosteroid MILWAUKEE, March 1, 2025 /PRNewswire-PRWeb/ -- Fifty-two weeks of Tezepelumab significantly reduces nasal polyps in adults with chronic rhinosinusitis...
↧